Applied Dna Sciences Profit Margin

Applied Dna Sciences (APDN) currently reports a profit margin of -41.98% as of March 2026. That compares with -8.25% in the prior-year period — down 408.7% year over year. That is below the Materials sector average of 16.45%. Use the charts on this page to explore Applied Dna Sciences's profit margin history and peer comparisons.

Applied Dna Sciences's profit margin decreased from -8.25% to -41.98% — a 408.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Dna Sciences's profit margin of -41.98% is lower than the Materials sector average of 16.45%. That is roughly 25619.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Applied Dna Sciences's current -41.98% should be judged against Materials norms (sector average: 16.45%) and against APDN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -41.98%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 16.45%. From there, open related valuation or income-statement pages for Applied Dna Sciences, and consider following APDN for alerts when major investors trade the stock.